nodes	percent_of_prediction	percent_of_DWPC	metapath
Azilsartan medoxomil—AGTR1—Allograft Rejection—MICA—ulcerative colitis	0.041	0.0954	CbGpPWpGaD
Azilsartan medoxomil—Hyperuricaemia—Mercaptopurine—ulcerative colitis	0.023	0.0444	CcSEcCtD
Azilsartan medoxomil—Blood uric acid increased—Mercaptopurine—ulcerative colitis	0.0217	0.0419	CcSEcCtD
Azilsartan medoxomil—Telmisartan—PPARG—ulcerative colitis	0.02	0.381	CrCbGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.0187	0.0436	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide GPCRs—CXCR1—ulcerative colitis	0.0182	0.0424	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Arf6 signaling events—ADRB2—ulcerative colitis	0.0163	0.0379	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide GPCRs—CXCR2—ulcerative colitis	0.0143	0.0332	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide GPCRs—CCR6—ulcerative colitis	0.0134	0.0312	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Arf6 trafficking events—ADRB2—ulcerative colitis	0.0129	0.0299	CbGpPWpGaD
Azilsartan medoxomil—Candesartan—PTGS1—ulcerative colitis	0.0119	0.227	CrCbGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL17A—ulcerative colitis	0.011	0.0257	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—ACE Inhibitor Pathway—TGFB1—ulcerative colitis	0.0104	0.0243	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL12B—ulcerative colitis	0.0103	0.0239	CbGpPWpGaD
Azilsartan medoxomil—Oedema peripheral—Nicotine—ulcerative colitis	0.0102	0.0197	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—CTLA4—ulcerative colitis	0.00964	0.0224	CbGpPWpGaD
Azilsartan medoxomil—Muscle spasms—Nicotine—ulcerative colitis	0.00867	0.0168	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CXCR1—ulcerative colitis	0.00857	0.0199	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—HLA-DQA1—ulcerative colitis	0.00849	0.0198	CbGpPWpGaD
Azilsartan medoxomil—Angioedema—Nicotine—ulcerative colitis	0.00824	0.0159	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—ulcerative colitis	0.00787	0.0152	CcSEcCtD
Azilsartan medoxomil—Blood creatinine increased—Mesalazine—ulcerative colitis	0.00786	0.0152	CcSEcCtD
Azilsartan medoxomil—AGTR1—Arf6 trafficking events—CDH1—ulcerative colitis	0.00777	0.0181	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—ABCB1—ulcerative colitis	0.00773	0.018	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCL20—ulcerative colitis	0.00753	0.0175	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL10—ulcerative colitis	0.0075	0.0174	CbGpPWpGaD
Azilsartan medoxomil—Skin disorder—Mercaptopurine—ulcerative colitis	0.00738	0.0143	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Nicotine—ulcerative colitis	0.00722	0.0139	CcSEcCtD
Azilsartan medoxomil—Telmisartan—ABCB1—ulcerative colitis	0.00717	0.137	CrCbGaD
Azilsartan medoxomil—Oedema peripheral—Budesonide—ulcerative colitis	0.00703	0.0136	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Budesonide—ulcerative colitis	0.00701	0.0136	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.00671	0.0156	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.00671	0.0156	CbGpPWpGaD
Azilsartan medoxomil—Gastrointestinal disorder—Mercaptopurine—ulcerative colitis	0.00656	0.0127	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Budesonide—ulcerative colitis	0.00648	0.0125	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Nicotine—ulcerative colitis	0.00636	0.0123	CcSEcCtD
Azilsartan medoxomil—Fatigue—Nicotine—ulcerative colitis	0.00635	0.0123	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.00631	0.0147	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—RELA—ulcerative colitis	0.00627	0.0146	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—HLA-DRB1—ulcerative colitis	0.00604	0.014	CbGpPWpGaD
Azilsartan medoxomil—Muscle spasms—Budesonide—ulcerative colitis	0.00597	0.0115	CcSEcCtD
Azilsartan medoxomil—Candesartan—ABCB1—ulcerative colitis	0.00578	0.11	CrCbGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.00575	0.0134	CbGpPWpGaD
Azilsartan medoxomil—Oedema peripheral—Mesalazine—ulcerative colitis	0.00572	0.011	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Mesalazine—ulcerative colitis	0.0057	0.011	CcSEcCtD
Azilsartan medoxomil—Angioedema—Budesonide—ulcerative colitis	0.00568	0.011	CcSEcCtD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NFKB1—ulcerative colitis	0.00529	0.0123	CbGpPWpGaD
Azilsartan medoxomil—Asthenia—Nicotine—ulcerative colitis	0.00528	0.0102	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Mesalazine—ulcerative colitis	0.00527	0.0102	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Budesonide—ulcerative colitis	0.00525	0.0101	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.00525	0.0122	CbGpPWpGaD
Azilsartan medoxomil—Pruritus—Nicotine—ulcerative colitis	0.00521	0.0101	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Mercaptopurine—ulcerative colitis	0.0052	0.01	CcSEcCtD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—GHRL—ulcerative colitis	0.00515	0.012	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.00508	0.0118	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.00505	0.0117	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Nicotine—ulcerative colitis	0.00504	0.00973	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Budesonide—ulcerative colitis	0.00497	0.00961	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.00494	0.0115	CbGpPWpGaD
Azilsartan medoxomil—Skin disorder—Budesonide—ulcerative colitis	0.00493	0.00952	CcSEcCtD
Azilsartan medoxomil—Dizziness—Nicotine—ulcerative colitis	0.00487	0.00941	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Mesalazine—ulcerative colitis	0.00486	0.00939	CcSEcCtD
Azilsartan medoxomil—Rash—Mercaptopurine—ulcerative colitis	0.00479	0.00926	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Mercaptopurine—ulcerative colitis	0.00479	0.00925	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.00469	0.00906	CcSEcCtD
Azilsartan medoxomil—Rash—Nicotine—ulcerative colitis	0.00464	0.00897	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Nicotine—ulcerative colitis	0.00464	0.00896	CcSEcCtD
Azilsartan medoxomil—Angioedema—Mesalazine—ulcerative colitis	0.00462	0.00892	CcSEcCtD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.0046	0.0107	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Mercaptopurine—ulcerative colitis	0.00451	0.00872	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.0045	0.0105	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IFNG—ulcerative colitis	0.00441	0.0103	CbGpPWpGaD
Azilsartan medoxomil—Skin disorder—Azathioprine—ulcerative colitis	0.0044	0.0085	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CXCR1—ulcerative colitis	0.00438	0.0102	CbGpPWpGaD
Azilsartan medoxomil—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.00438	0.00846	CcSEcCtD
Azilsartan medoxomil—Nausea—Nicotine—ulcerative colitis	0.00437	0.00845	CcSEcCtD
Azilsartan medoxomil—Fatigue—Budesonide—ulcerative colitis	0.00437	0.00845	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.00435	0.0101	CbGpPWpGaD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.00427	0.00825	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.00423	0.00984	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—ulcerative colitis	0.00412	0.00957	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—CXCL8—ulcerative colitis	0.0041	0.00954	CbGpPWpGaD
Azilsartan medoxomil—Connective tissue disorder—Hydrocortisone—ulcerative colitis	0.00406	0.00784	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Mesalazine—ulcerative colitis	0.00404	0.00781	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Mesalazine—ulcerative colitis	0.00401	0.00774	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL1B—ulcerative colitis	0.00393	0.00915	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL2—ulcerative colitis	0.00392	0.00912	CbGpPWpGaD
Azilsartan medoxomil—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.00391	0.00755	CcSEcCtD
Azilsartan medoxomil—Losartan—ALB—ulcerative colitis	0.0039	0.0744	CrCbGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCL20—ulcerative colitis	0.00384	0.00894	CbGpPWpGaD
Azilsartan medoxomil—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.00381	0.00736	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.00372	0.00866	CbGpPWpGaD
Azilsartan medoxomil—Losartan—ABCB1—ulcerative colitis	0.00372	0.071	CrCbGaD
Azilsartan medoxomil—Asthenia—Budesonide—ulcerative colitis	0.00364	0.00703	CcSEcCtD
Azilsartan medoxomil—Pruritus—Budesonide—ulcerative colitis	0.00359	0.00693	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.00356	0.00688	CcSEcCtD
Azilsartan medoxomil—Fatigue—Mesalazine—ulcerative colitis	0.00356	0.00687	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Methylprednisolone—ulcerative colitis	0.00352	0.0068	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Budesonide—ulcerative colitis	0.00347	0.0067	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CXCR2—ulcerative colitis	0.00343	0.00797	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.00341	0.00793	CbGpPWpGaD
Azilsartan medoxomil—Angioedema—Prednisolone—ulcerative colitis	0.00336	0.00649	CcSEcCtD
Azilsartan medoxomil—Dizziness—Budesonide—ulcerative colitis	0.00335	0.00648	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.00329	0.00766	CbGpPWpGaD
Azilsartan medoxomil—Angioedema—Hydrocortisone—ulcerative colitis	0.00328	0.00634	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCR6—ulcerative colitis	0.00322	0.00749	CbGpPWpGaD
Azilsartan medoxomil—Angiopathy—Dexamethasone—ulcerative colitis	0.0032	0.00618	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Betamethasone—ulcerative colitis	0.0032	0.00618	CcSEcCtD
Azilsartan medoxomil—Rash—Budesonide—ulcerative colitis	0.0032	0.00618	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Budesonide—ulcerative colitis	0.00319	0.00617	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Azathioprine—ulcerative colitis	0.0031	0.00598	CcSEcCtD
Azilsartan medoxomil—Angioedema—Triamcinolone—ulcerative colitis	0.00309	0.00597	CcSEcCtD
Azilsartan medoxomil—Angioedema—Methylprednisolone—ulcerative colitis	0.00308	0.00596	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—TGFB1—ulcerative colitis	0.00306	0.00711	CbGpPWpGaD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.00304	0.00587	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Prednisone—ulcerative colitis	0.00302	0.00583	CcSEcCtD
Azilsartan medoxomil—Nausea—Budesonide—ulcerative colitis	0.00301	0.00582	CcSEcCtD
Azilsartan medoxomil—Dizziness—Azathioprine—ulcerative colitis	0.00299	0.00578	CcSEcCtD
Azilsartan medoxomil—Asthenia—Mesalazine—ulcerative colitis	0.00296	0.00572	CcSEcCtD
Azilsartan medoxomil—Pruritus—Mesalazine—ulcerative colitis	0.00292	0.00564	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.00288	0.00556	CcSEcCtD
Azilsartan medoxomil—Rash—Azathioprine—ulcerative colitis	0.00285	0.00551	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—TNF—ulcerative colitis	0.00285	0.00664	CbGpPWpGaD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.00285	0.00551	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Azathioprine—ulcerative colitis	0.00285	0.00551	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Hydrocortisone—ulcerative colitis	0.00285	0.0055	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—PTGER4—ulcerative colitis	0.00284	0.0066	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.00282	0.00657	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Mesalazine—ulcerative colitis	0.00282	0.00545	CcSEcCtD
Azilsartan medoxomil—Angioedema—Dexamethasone—ulcerative colitis	0.00281	0.00542	CcSEcCtD
Azilsartan medoxomil—Angioedema—Betamethasone—ulcerative colitis	0.00281	0.00542	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Prednisone—ulcerative colitis	0.00279	0.00538	CcSEcCtD
Azilsartan medoxomil—Dizziness—Mesalazine—ulcerative colitis	0.00273	0.00527	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.0027	0.00522	CcSEcCtD
Azilsartan medoxomil—Nausea—Azathioprine—ulcerative colitis	0.00269	0.0052	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Methylprednisolone—ulcerative colitis	0.00268	0.00517	CcSEcCtD
Azilsartan medoxomil—Rash—Mesalazine—ulcerative colitis	0.0026	0.00502	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Mesalazine—ulcerative colitis	0.0026	0.00502	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—GHRL—ulcerative colitis	0.0026	0.00604	CbGpPWpGaD
Azilsartan medoxomil—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.00253	0.00489	CcSEcCtD
Azilsartan medoxomil—Fatigue—Hydrocortisone—ulcerative colitis	0.00253	0.00488	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCR1—ulcerative colitis	0.00247	0.00576	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Betamethasone—ulcerative colitis	0.00246	0.00475	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Dexamethasone—ulcerative colitis	0.00246	0.00475	CcSEcCtD
Azilsartan medoxomil—Nausea—Mesalazine—ulcerative colitis	0.00245	0.00473	CcSEcCtD
Azilsartan medoxomil—Angioedema—Prednisone—ulcerative colitis	0.00244	0.00472	CcSEcCtD
Azilsartan medoxomil—Fatigue—Triamcinolone—ulcerative colitis	0.00238	0.0046	CcSEcCtD
Azilsartan medoxomil—Fatigue—Methylprednisolone—ulcerative colitis	0.00238	0.00459	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.00226	0.00437	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCR1—ulcerative colitis	0.00225	0.00523	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCL20—ulcerative colitis	0.00217	0.00505	CbGpPWpGaD
Azilsartan medoxomil—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.00216	0.00418	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.00216	0.00418	CcSEcCtD
Azilsartan medoxomil—Fatigue—Dexamethasone—ulcerative colitis	0.00216	0.00417	CcSEcCtD
Azilsartan medoxomil—Fatigue—Betamethasone—ulcerative colitis	0.00216	0.00417	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—ADRB2—ulcerative colitis	0.00215	0.005	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Prednisone—ulcerative colitis	0.00214	0.00413	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Prednisone—ulcerative colitis	0.00212	0.00409	CcSEcCtD
Azilsartan medoxomil—Asthenia—Hydrocortisone—ulcerative colitis	0.0021	0.00406	CcSEcCtD
Azilsartan medoxomil—Pruritus—Hydrocortisone—ulcerative colitis	0.00207	0.00401	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GNA12—ulcerative colitis	0.00204	0.00475	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.00203	0.00473	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.00202	0.00469	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Hydrocortisone—ulcerative colitis	0.00201	0.00388	CcSEcCtD
Azilsartan medoxomil—Dizziness—Prednisolone—ulcerative colitis	0.00199	0.00384	CcSEcCtD
Azilsartan medoxomil—Asthenia—Triamcinolone—ulcerative colitis	0.00198	0.00383	CcSEcCtD
Azilsartan medoxomil—Asthenia—Methylprednisolone—ulcerative colitis	0.00198	0.00382	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL20—ulcerative colitis	0.00197	0.00459	CbGpPWpGaD
Azilsartan medoxomil—Pruritus—Triamcinolone—ulcerative colitis	0.00195	0.00377	CcSEcCtD
Azilsartan medoxomil—Pruritus—Methylprednisolone—ulcerative colitis	0.00195	0.00377	CcSEcCtD
Azilsartan medoxomil—Dizziness—Hydrocortisone—ulcerative colitis	0.00194	0.00375	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCR2—ulcerative colitis	0.00194	0.0045	CbGpPWpGaD
Azilsartan medoxomil—Rash—Prednisolone—ulcerative colitis	0.00189	0.00366	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Prednisolone—ulcerative colitis	0.00189	0.00365	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Methylprednisolone—ulcerative colitis	0.00189	0.00364	CcSEcCtD
Azilsartan medoxomil—Fatigue—Prednisone—ulcerative colitis	0.00188	0.00363	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GNA12—ulcerative colitis	0.00185	0.00431	CbGpPWpGaD
Azilsartan medoxomil—Rash—Hydrocortisone—ulcerative colitis	0.00185	0.00357	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Hydrocortisone—ulcerative colitis	0.00185	0.00357	CcSEcCtD
Azilsartan medoxomil—Dizziness—Triamcinolone—ulcerative colitis	0.00183	0.00353	CcSEcCtD
Azilsartan medoxomil—Dizziness—Methylprednisolone—ulcerative colitis	0.00182	0.00352	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCR6—ulcerative colitis	0.00182	0.00423	CbGpPWpGaD
Azilsartan medoxomil—Asthenia—Betamethasone—ulcerative colitis	0.0018	0.00347	CcSEcCtD
Azilsartan medoxomil—Asthenia—Dexamethasone—ulcerative colitis	0.0018	0.00347	CcSEcCtD
Azilsartan medoxomil—Nausea—Prednisolone—ulcerative colitis	0.00178	0.00345	CcSEcCtD
Azilsartan medoxomil—Pruritus—Betamethasone—ulcerative colitis	0.00177	0.00342	CcSEcCtD
Azilsartan medoxomil—Pruritus—Dexamethasone—ulcerative colitis	0.00177	0.00342	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCR2—ulcerative colitis	0.00176	0.00409	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Hydrocortisone—ulcerative colitis	0.00174	0.00337	CcSEcCtD
Azilsartan medoxomil—Rash—Triamcinolone—ulcerative colitis	0.00174	0.00336	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Triamcinolone—ulcerative colitis	0.00174	0.00336	CcSEcCtD
Azilsartan medoxomil—Rash—Methylprednisolone—ulcerative colitis	0.00174	0.00336	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Methylprednisolone—ulcerative colitis	0.00174	0.00335	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Dexamethasone—ulcerative colitis	0.00171	0.00331	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Betamethasone—ulcerative colitis	0.00171	0.00331	CcSEcCtD
Azilsartan medoxomil—Dizziness—Betamethasone—ulcerative colitis	0.00166	0.0032	CcSEcCtD
Azilsartan medoxomil—Dizziness—Dexamethasone—ulcerative colitis	0.00166	0.0032	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCR6—ulcerative colitis	0.00165	0.00385	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Triamcinolone—ulcerative colitis	0.00164	0.00317	CcSEcCtD
Azilsartan medoxomil—Nausea—Methylprednisolone—ulcerative colitis	0.00164	0.00316	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SEL1L—ulcerative colitis	0.00161	0.00375	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PTGER4—ulcerative colitis	0.0016	0.00373	CbGpPWpGaD
Azilsartan medoxomil—Rash—Betamethasone—ulcerative colitis	0.00158	0.00305	CcSEcCtD
Azilsartan medoxomil—Rash—Dexamethasone—ulcerative colitis	0.00158	0.00305	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Dexamethasone—ulcerative colitis	0.00158	0.00305	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Betamethasone—ulcerative colitis	0.00158	0.00305	CcSEcCtD
Azilsartan medoxomil—Asthenia—Prednisone—ulcerative colitis	0.00157	0.00302	CcSEcCtD
Azilsartan medoxomil—Pruritus—Prednisone—ulcerative colitis	0.00154	0.00298	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Prednisone—ulcerative colitis	0.00149	0.00288	CcSEcCtD
Azilsartan medoxomil—Nausea—Dexamethasone—ulcerative colitis	0.00149	0.00288	CcSEcCtD
Azilsartan medoxomil—Nausea—Betamethasone—ulcerative colitis	0.00149	0.00288	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GHRL—ulcerative colitis	0.00147	0.00341	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PTGER4—ulcerative colitis	0.00146	0.00339	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Prednisone—ulcerative colitis	0.00144	0.00279	CcSEcCtD
Azilsartan medoxomil—Rash—Prednisone—ulcerative colitis	0.00138	0.00266	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Prednisone—ulcerative colitis	0.00137	0.00266	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.00136	0.00317	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GHRL—ulcerative colitis	0.00133	0.0031	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCR1—ulcerative colitis	0.00133	0.00309	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Prednisone—ulcerative colitis	0.0013	0.0025	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CALM3—ulcerative colitis	0.00129	0.003	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—ADRB2—ulcerative colitis	0.00121	0.00283	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL20—ulcerative colitis	0.00117	0.00271	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—ADRB2—ulcerative colitis	0.0011	0.00257	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GNA12—ulcerative colitis	0.0011	0.00255	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCR2—ulcerative colitis	0.00104	0.00242	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CXCL8—ulcerative colitis	0.00104	0.00241	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.00103	0.00241	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—ADCY5—ulcerative colitis	0.00103	0.0024	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCR6—ulcerative colitis	0.000977	0.00227	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—ADCY5—ulcerative colitis	0.000936	0.00218	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MAML2—ulcerative colitis	0.000926	0.00215	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PTGER4—ulcerative colitis	0.00086	0.002	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GHRL—ulcerative colitis	0.000787	0.00183	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CALM3—ulcerative colitis	0.000762	0.00177	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—RIPK2—ulcerative colitis	0.000751	0.00175	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ADRB2—ulcerative colitis	0.000652	0.00152	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—JAK2—ulcerative colitis	0.000643	0.0015	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000587	0.00136	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—JAK2—ulcerative colitis	0.000584	0.00136	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—IL2—ulcerative colitis	0.000561	0.0013	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ADCY5—ulcerative colitis	0.000553	0.00129	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCL8—ulcerative colitis	0.000533	0.00124	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL2—ulcerative colitis	0.000509	0.00118	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—JAK2—ulcerative colitis	0.000345	0.000802	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—RELA—ulcerative colitis	0.000334	0.000777	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCL8—ulcerative colitis	0.000315	0.000732	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL2—ulcerative colitis	0.000301	0.0007	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL6—ulcerative colitis	0.000299	0.000696	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MMP9—ulcerative colitis	0.000285	0.000662	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NFKB1—ulcerative colitis	0.000282	0.000655	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—STAT3—ulcerative colitis	0.000253	0.000589	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TGFB1—ulcerative colitis	0.000235	0.000546	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TP53—ulcerative colitis	0.000193	0.000449	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL6—ulcerative colitis	0.000177	0.000411	CbGpPWpGaD
